. Author manuscript; available in PMC: 2013 Jun 4.

Published in final edited form as: Mol Pharm. 2012 May 2;9(6):1795–1802. doi: 10.1021/mp300098t

TABLE 1.

Inhibition efficiency (%) of different treatments on the accumulation of PPCs in HCT116 cells.^a

Drug	Lipid raft endocytosis inhibitor (nystatin)	Macropinocytosis inhibitors		Clathrin-mediated endocytosis inhibitors

		Cytochalasin D	EIPA	Hypertonic medium	Chlorpromazine
BBR3464	ns	−13^*	−13^**	ns	+33^*
TriplatinNC	−41^**	−32^**	−30^**	ns	ns

; See Materials and Methods. Data are shown as mean (n=3). For SD values, see supplemental Figures S5–S8.

p = 0.05,

^**

p<0.01, Student t test. ns: non-significant